Key result
Tricyclic antidepressants can cause orthostatic hypotension and delay conduction, whereas newer antidepressants like bupropion and SSRIs appear safer in patients with conduction disease.
Why the study?
What are the cardiovascular safety profiles and effects of various antidepressant drugs in depressed patients?
Population
Depressed patients, including those with and without preexisting cardiac disease
Design
Review
Authors
Loading...
Caution advised before TCA use in bundle branch block; extends safety data for patients without conduction disease.
What are the cardiovascular safety profiles and effects of various antidepressant drugs in depressed patients?
While tricyclic antidepressants pose significant conduction risks in patients with preexisting cardiac disease, newer antidepressants like SSRIs and bupropion appear to have a safer cardiovascular profile but require further rigorous testing in high-risk patients.
Glassman et al. (1993) conducted a review in Depression. Antidepressant drugs was evaluated. Tricyclic antidepressants can cause orthostatic hypotension and delay conduction, whereas newer antidepressants like bupropion and SSRIs appear safer in patients with conduction disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: